I-131 Tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: Radiation dose to the testes

被引：0
|
作者：
Hattori, Naoya [1 ]
Gopal, Ajay [1 ]
Fisher, Darrell [2 ]
Durack, Lawrence [1 ]
Shields, Andrew [1 ]
Press, Oliver [1 ]
Rajendran, Joseph [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Pacific Northwest Natl Lab, Richland, WA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1836
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dosimetry and radioimmunotherapy of non-Hodgkin's lymphoma
    Postema, EJ
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (12) : 2126 - 2127
  • [42] Efficacy and safety of Bexxar® (tositumomab and iodine I 131 tositumomab) in obese patients with low-grade non-Hodgkin's lymphoma.
    Wahl, R
    Goldsmith, SJ
    Zasadny, KR
    Alavi, A
    Divgi, C
    Hankins, J
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 415P - 415P
  • [43] Radioimmunotherapy in non-Hodgkin lymphoma
    Chanan-Khan, A
    Czuczman, MS
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (05) : 484 - 489
  • [44] Radioimmunotherapy (RIT) of non-Hodgkin's lymphoma (NHL) with I-131 anti-CD20 monoclonal antibody (Bexxar™).: Preliminary results
    Antonescu, C
    Buchegger, F
    Kosinski, M
    Ketterer, N
    Kovacsovics, T
    Helg, C
    Delaloye, AB
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 980 - 980
  • [45] Assessment of absorbed dose and therapeutic response of tumor in repeated high-dose I-131 antiCD20 monoclonal antibody (rituximab) radioimmunotherapy for non-Hodgkin's lymphoma
    Byun, B.
    Kim, K.
    Suh, S.
    Kang, H.
    Choi, T.
    Lee, J.
    Woo, S.
    Cheon, G.
    Choi, C.
    Lim, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S360 - S360
  • [46] Bexxar, iodine I 131 tositumomab, effective in long term follow-up of non-Hodgkin's lymphoma
    Kaminski, Mark
    CANCER BIOLOGY & THERAPY, 2007, 6 (07) : 996 - 997
  • [47] 131I-Tositumomab (Bexxar®) Therapy of Refractory/Relapsed Non-Hodgkin Lymphoma: Clinical Experience
    Iagaru, A.
    Knox, S.
    Goris, M. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S148 - S149
  • [48] DOSE FRACTIONATED RADIOIMMUNOTHERAPY OF LYMPHOMA WITH I-131 LYM-1
    DENARDO, SJ
    DENARDO, GI
    MACEY, DJ
    MILLS, SL
    OGRADY, LF
    MCGAHAN, JP
    HU, E
    EPSTEIN, AL
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 313 - 313
  • [49] Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma
    Eary, JF
    Krohn, KA
    Press, OW
    Durack, L
    Bernstein, ID
    NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (07): : 635 - 638
  • [50] Radioimmunotherapy (RIT) for non-Hodgkin's lymphoma. Preliminary results using I-131 labelled anti-CD-20 antibody (Tositumomab) in 47 patients at two years post-therapy.
    Jan, H
    Britton, KE
    Davies, A
    Sobnack, R
    Foley, RR
    Barlow, R
    Mather, SJ
    Ellison, D
    Rohatiner, AZ
    Lister, TA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 980 - 980
12345